Explore more publications!
Healthy Living South Dakota
Got News to Share?

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on February 19, 2026

Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth
Feb. 19, 2026

Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth

Indeterminate GlobeNewswire
Zealand Pharma convenes its Annual General Meeting 2026
Feb. 19, 2026

Zealand Pharma convenes its Annual General Meeting 2026

Indeterminate GlobeNewswire
Clearsense to Present Case Study Session on IT Cost Optimization at ViVE 2026
Feb. 19, 2026

Clearsense to Present Case Study Session on IT Cost Optimization at ViVE 2026

Indeterminate GlobeNewswire
Labviva AI Procurement Solutions Help Research Universities Navigate Rising Costs and Funding Cuts
Feb. 19, 2026

Labviva AI Procurement Solutions Help Research Universities Navigate Rising Costs and Funding Cuts

Indeterminate GlobeNewswire
Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors
Feb. 19, 2026

Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors

Indeterminate GlobeNewswire
ORYZON to Participate in Upcoming Events in February and March
Feb. 19, 2026

ORYZON to Participate in Upcoming Events in February and March

Indeterminate GlobeNewswire
Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
Feb. 19, 2026

Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026

Indeterminate GlobeNewswire
Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma
Feb. 19, 2026

Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma

Indeterminate GlobeNewswire
Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights
Feb. 19, 2026

Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights

Indeterminate GlobeNewswire
Protara Therapeutics to Participate in Upcoming Investor Conferences
Feb. 19, 2026

Protara Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365
Feb. 19, 2026

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

Indeterminate GlobeNewswire
Cassava Announces Closure of U.S. Department of Justice Investigation
Feb. 19, 2026

Cassava Announces Closure of U.S. Department of Justice Investigation

Indeterminate GlobeNewswire
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
Feb. 19, 2026

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
Feb. 19, 2026

Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2025 Financial Results and Business Updates

Indeterminate GlobeNewswire
Reunion Neuroscience to Participate in Upcoming Investor Conferences
Feb. 19, 2026

Reunion Neuroscience to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
Feb. 19, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
Feb. 19, 2026

Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza

Indeterminate GlobeNewswire
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Feb. 19, 2026

Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Indeterminate GlobeNewswire
Kane Biotech Expands Commercial Activities in the United States
Feb. 19, 2026

Kane Biotech Expands Commercial Activities in the United States

Indeterminate GlobeNewswire
Step Pharma secures €2.5 million EIC grant to accelerate development of dencatistat for CTPS2 null gynaecological tumours
Feb. 19, 2026

Step Pharma secures €2.5 million EIC grant to accelerate development of dencatistat for CTPS2 null gynaecological tumours

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions